BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31730885)

  • 1. In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease.
    Zhu XY; Xia HG; Wang ZH; Li B; Jiang HY; Li DL; Jin R; Jin Y
    Toxicol Lett; 2020 Feb; 319():85-94. PubMed ID: 31730885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport.
    Kawano Y; Nishiumi S; Tanaka S; Nobutani K; Miki A; Yano Y; Seo Y; Kutsumi H; Ashida H; Azuma T; Yoshida M
    Arch Biochem Biophys; 2010 Dec; 504(2):221-7. PubMed ID: 20831858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.
    Uno S; Nebert DW; Makishima M
    Food Chem Toxicol; 2018 Mar; 113():73-82. PubMed ID: 29366871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
    Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
    Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of benzo [a] pyrene regulating lipid metabolism via aryl hydrocarbon receptor.
    Lou W; Zhang MD; Chen Q; Bai TY; Hu YX; Gao F; Li J; Lv XL; Zhang Q; Chang FH
    Lipids Health Dis; 2022 Jan; 21(1):13. PubMed ID: 35057794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway.
    Cherng SH; Lin P; Yang JL; Hsu SL; Lee H
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):63-8. PubMed ID: 11141357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnane X receptor regulates the AhR/Cyp1A1 pathway and protects liver cells from benzo-[α]-pyrene-induced DNA damage.
    Cui H; Gu X; Chen J; Xie Y; Ke S; Wu J; Golovko A; Morpurgo B; Yan C; Phillips TD; Xie W; Luo J; Zhou Z; Tian Y
    Toxicol Lett; 2017 Jun; 275():67-76. PubMed ID: 28428138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.
    Lee JH; Wada T; Febbraio M; He J; Matsubara T; Lee MJ; Gonzalez FJ; Xie W
    Gastroenterology; 2010 Aug; 139(2):653-63. PubMed ID: 20303349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal inhibiting interactive mechanism between the estrogen receptor and aryl hydrocarbon receptor signaling pathways in goldfish (Carassius auratus) exposed to 17β-estradiol and benzo[a]pyrene.
    Yan Z; Lu G; He J
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):17-23. PubMed ID: 22425873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
    Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
    Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
    J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
    Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway.
    Braeuning A; Köhle C; Buchmann A; Schwarz M
    Toxicol Sci; 2011 Jul; 122(1):16-25. PubMed ID: 21498875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells.
    Tanner N; Kubik L; Luckert C; Thomas M; Hofmann U; Zanger UM; Böhmert L; Lampen A; Braeuning A
    Drug Metab Dispos; 2018 Apr; 46(4):326-335. PubMed ID: 29330220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-27b Depletion Enhances Endotrophic and Intravascular Lipid Accumulation and Induces Adipocyte Hyperplasia in Zebrafish.
    Hsu CC; Lai CY; Lin CY; Yeh KY; Her GM
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.